PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Clin Pathol. 2007 August; 60(8): 958–959.
PMCID: PMC1994501

CD10 positivity in breast epithelial neoplasms

We read with great interest the study of Kalof et al1 concerning immunostaining patterns of myoepithelial cells in breast lesions. The authors identified focal CD10 staining of breast epithelial cells. We recently saw a case of co‐existent intraductal papilloma, intraductal carcinoma and infiltrating ductal carcinoma of breast ((figsfigs 1 and 22).). The cytoplasm of epithelial cells in all components was pan‐cytokeratin positive and CD10 positive ((figsfigs 3 and 44)) in addition to myoepithelial CD10 staining in the intraductal papilloma. Kalof et al also mentioned the study of Moritani et al,2 which showed lack of CD10 positivity in both non‐neoplastic and neoplastic breast epithelia. Methodological differences were mentioned by Kalof et al as possible reason(s) for the discrepant results between their study and that of Moritani et al. Comparison of the methods used in the study of Kalof et al, that of Moritani et al and our case study (table 11)) indicates that CD10 immunostaining methods using 56C6 clone and/or non‐heat antigen retrieval detect CD10 expression in non‐neoplastic and neoplastic breast epithelial cells.

figure cp47191.f1
Figure 1 H and E stain (×200) showing a papilloma.
Table thumbnail
Table 1 Comparison of CD10 immunohistochemical methods
figure cp47191.f2
Figure 2 H and E stain (×200) showing an invasive ductal carcinoma.
figure cp47191.f3
Figure 3 CDI0 immunostain (×400). Left: epithelial cytoplasmic positivity in papilloma; right: cytoplasmic positivity in invasive ductal carcinoma.
figure cp47191.f4
Figure 4 CD10 immunostain (×1000) showing epithelial cytoplasmic staining.

In their in vitro study of phenotypic and functional characterisation of a multipotent epithelial cell in the normal adult human breast, Stingl et al3 identified a bipotent human breast epithelial cell progenitor that can express MUC‐1, CD10 and epithelial‐specific antigen and can generate mixed colonies of both epithelial and myoepithelial cells. Therefore, it is possible to see CD10 expression in the breast luminal epithelial cells arising from these bipotent cells.

Although we cannot draw any conclusions about CD10 expression in breast epithelium based on the study by Kalof et al and our single case result, CD10 positivity in epithelial cells should not rule out the possibility of primary breast cancer during the work‐up of a metastatic adenocarcinoma. Larger studies using different CD10 antibody clones and different antigen retrieval methods could help clarify CD10 positivity in mammary epithelium.

Footnotes

Competing interests: None declared.

References

1. Kalof A N, Tam D, Beatty B. et al Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol 2004. 57625–629.629. [PMC free article] [PubMed]
2. Moritani S, Kushima R, Sugihara H. et al Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 2002. 15397–405.405. [PubMed]
3. Stingl J, Eaves C J, Kuusk U. et al Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 1998. 63201–213.213. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Group